vs
Side-by-side financial comparison of MACROGENICS INC (MGNX) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
MACROGENICS INC is the larger business by last-quarter revenue ($41.2M vs $31.4M, roughly 1.3× Ponce Financial Group, Inc.). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs 37.6%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $42.8M). Over the past eight quarters, MACROGENICS INC's revenue compounded faster (112.8% CAGR vs 23.7%).
MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
MGNX vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.2M | $31.4M |
| Net Profit | — | $10.1M |
| Gross Margin | — | — |
| Operating Margin | -29.3% | 43.6% |
| Net Margin | — | 36.3% |
| Revenue YoY | 113.0% | 37.6% |
| Net Profit YoY | — | 245.6% |
| EPS (diluted) | $-0.23 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.2M | $31.4M | ||
| Q3 25 | $72.8M | $26.7M | ||
| Q2 25 | $22.2M | $26.5M | ||
| Q1 25 | $13.2M | $24.6M | ||
| Q4 24 | $19.4M | $22.8M | ||
| Q3 24 | $110.7M | $20.2M | ||
| Q2 24 | $10.8M | $20.2M | ||
| Q1 24 | $9.1M | $20.5M |
| Q4 25 | — | $10.1M | ||
| Q3 25 | $16.8M | $6.5M | ||
| Q2 25 | $-36.3M | $6.1M | ||
| Q1 25 | $-41.0M | $6.0M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | $56.3M | $2.4M | ||
| Q2 24 | $-55.7M | $3.2M | ||
| Q1 24 | $-52.2M | $2.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 98.8% | — | ||
| Q3 24 | 99.8% | — | ||
| Q2 24 | 98.4% | — | ||
| Q1 24 | 97.0% | — |
| Q4 25 | -29.3% | 43.6% | ||
| Q3 25 | 25.6% | 32.8% | ||
| Q2 25 | -165.3% | 30.2% | ||
| Q1 25 | -323.1% | 32.5% | ||
| Q4 24 | -273.0% | 19.6% | ||
| Q3 24 | 48.9% | 15.2% | ||
| Q2 24 | -538.9% | 21.8% | ||
| Q1 24 | -590.4% | 18.3% |
| Q4 25 | — | 36.3% | ||
| Q3 25 | 23.1% | 24.3% | ||
| Q2 25 | -163.0% | 23.0% | ||
| Q1 25 | -311.1% | 24.2% | ||
| Q4 24 | — | 14.1% | ||
| Q3 24 | 50.9% | 12.1% | ||
| Q2 24 | -515.6% | 15.8% | ||
| Q1 24 | -573.3% | 11.8% |
| Q4 25 | $-0.23 | $0.43 | ||
| Q3 25 | $0.27 | $0.27 | ||
| Q2 25 | $-0.57 | $0.25 | ||
| Q1 25 | $-0.65 | $0.25 | ||
| Q4 24 | $-0.24 | $0.11 | ||
| Q3 24 | $0.90 | $0.10 | ||
| Q2 24 | $-0.89 | $0.14 | ||
| Q1 24 | $-0.84 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.2M | $126.2M |
| Total DebtLower is stronger | — | $596.1M |
| Stockholders' EquityBook value | $55.6M | $541.5M |
| Total Assets | $256.8M | $3.2B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.2M | $126.2M | ||
| Q3 25 | $80.1M | $146.6M | ||
| Q2 25 | $130.7M | $126.6M | ||
| Q1 25 | $145.6M | $129.9M | ||
| Q4 24 | $182.8M | $139.8M | ||
| Q3 24 | $179.6M | $155.8M | ||
| Q2 24 | $83.9M | $103.2M | ||
| Q1 24 | $80.4M | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $55.6M | $541.5M | ||
| Q3 25 | $67.0M | $529.8M | ||
| Q2 25 | $46.6M | $521.1M | ||
| Q1 25 | $79.1M | $513.9M | ||
| Q4 24 | $116.1M | $505.5M | ||
| Q3 24 | $120.1M | $504.6M | ||
| Q2 24 | $57.8M | $497.7M | ||
| Q1 24 | $106.2M | $493.7M |
| Q4 25 | $256.8M | $3.2B | ||
| Q3 25 | $270.8M | $3.2B | ||
| Q2 25 | $245.4M | $3.2B | ||
| Q1 25 | $224.6M | $3.1B | ||
| Q4 24 | $261.7M | $3.0B | ||
| Q3 24 | $264.5M | $3.0B | ||
| Q2 24 | $201.1M | $2.8B | ||
| Q1 24 | $248.3M | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.0M | $55.6M |
| Free Cash FlowOCF − Capex | $42.8M | $54.6M |
| FCF MarginFCF / Revenue | 103.8% | 173.9% |
| Capex IntensityCapex / Revenue | 0.6% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-83.0M | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.0M | $55.6M | ||
| Q3 25 | $-30.2M | $1.4M | ||
| Q2 25 | $-47.0M | $6.2M | ||
| Q1 25 | $-46.9M | $13.1M | ||
| Q4 24 | $-38.4M | $7.2M | ||
| Q3 24 | $60.2M | $-14.6M | ||
| Q2 24 | $-44.5M | $-2.6M | ||
| Q1 24 | $-45.6M | $1.5M |
| Q4 25 | $42.8M | $54.6M | ||
| Q3 25 | $-30.6M | $786.0K | ||
| Q2 25 | $-47.7M | $5.9M | ||
| Q1 25 | $-47.4M | $12.9M | ||
| Q4 24 | $-39.0M | $4.5M | ||
| Q3 24 | $59.6M | $-15.0M | ||
| Q2 24 | $-45.5M | $-2.6M | ||
| Q1 24 | $-47.1M | $-315.0K |
| Q4 25 | 103.8% | 173.9% | ||
| Q3 25 | -42.0% | 2.9% | ||
| Q2 25 | -214.5% | 22.4% | ||
| Q1 25 | -359.5% | 52.6% | ||
| Q4 24 | -201.7% | 19.7% | ||
| Q3 24 | 53.8% | -74.1% | ||
| Q2 24 | -421.6% | -13.0% | ||
| Q1 24 | -517.4% | -1.5% |
| Q4 25 | 0.6% | 3.1% | ||
| Q3 25 | 0.6% | 2.3% | ||
| Q2 25 | 3.2% | 1.0% | ||
| Q1 25 | 4.0% | 0.6% | ||
| Q4 24 | 3.2% | 11.9% | ||
| Q3 24 | 0.5% | 2.0% | ||
| Q2 24 | 9.6% | 0.3% | ||
| Q1 24 | 16.0% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | -1.79× | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | 1.07× | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
PDLB
Segment breakdown not available.
